Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets.

Journal: Cell Metabolism

Published: 2020-11-06

DOI: 10.1016/j.cmet.2020.10.012

Affiliations: 10

Authors: 17

Go to article
Institutions Share
Fudan University Shanghai Cancer Center (FUSCC), China 0.61
Shanghai Medical College (SHMC), Fudan University, China 0.25
Peking University (PKU), China 0.06
Cancer Research Center of Marseille (CRCM), France 0.06
Children's Hospital, Fudan University, China 0.03